v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 25,000 $ 35,000
Cost of goods sold 2,909
Gross profit 22,091 35,000
Operating Expenses:    
Research and development 1,714,327 1,058,131
General and administrative 3,115,298 3,086,121
Total Operating Expenses 4,829,625 4,144,252
Loss From Operations (4,807,534) (4,109,252)
Other (Expense) Income:    
Interest income 99,966 162,597
Other income 1,888 149,021
Gain on exchange of warrants 1,711,698
Change in fair value of warrant liabilities (634,119) (137,319)
Total Other (Expense) Income (532,265) 1,885,997
Net Loss $ (5,339,799) $ (2,223,255)
Net Loss Per Share - Basic $ (0.64) $ (0.33)
Net Loss Per Share - Diluted $ (0.64) $ (0.33)
Weighted Average Common Shares Outstanding - Basic 8,357,143 6,671,382
Weighted Average Common Shares Outstanding - Diluted 8,357,143 6,671,382

Source